Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin and Docetaxel in Recurrent/Metastatic SCCHN
NCT00557206Phase 2Terminated
- Start
- Apr 2005
- Primary completion
- Nov 2009
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, docetaxel in squamous cell carcinoma of the head and neck (HNSCC). Started Apr 2005; status: terminated.
02
Drugs
oxaliplatindocetaxel
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00557206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00557206.